Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
Clinical trial NCT05383742 · RECRUITING
Trial details
- NCT number
- NCT05383742
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-07
- Primary completion
- 2028-04-30
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.